Company Filing History:

Years Active: 2000-2004
Title: Berma M Kinsey: Innovator in Genetic Immunization and Liposomal Formulations
Introduction
Berma M Kinsey is a notable inventor based in Houston, TX (US). He has made significant contributions to the fields of genetic immunization and pharmaceutical formulations. With a total of 3 patents, his work has the potential to impact medical science and vaccine delivery systems.
Latest Patents
One of his latest patents is titled "Macroaggregated protein conjugates as oral genetic immunization delivery agents." This invention focuses on developing an expression vector that contains an antigenic genomic sequence bound to an aggregated protein-polycationic polymer conjugate. The primary aim is to utilize this expression vector as an oral DNA vaccine to induce an immune response. Another significant patent is "Stabilization of lipid:DNA formulations during nebulization." This invention provides a liposomal aerosol composition that includes a pharmaceutical compound, a cationic lipid, a neutral co-lipid, and tryptone. It also presents a nebulized cationic lipid: neutral co-lipid: DNA suspension useful for lipid-DNA transfections.
Career Highlights
Throughout his career, Berma M Kinsey has worked with the Research Development Foundation, where he has contributed to various innovative projects. His expertise in genetic immunization and lipid formulations has positioned him as a valuable asset in the research community.
Collaborations
He has collaborated with notable individuals such as Charles L Densmore, Jr. and J Vernon Knight, further enhancing the scope and impact of his work.
Conclusion
Berma M Kinsey's innovative contributions to genetic immunization and pharmaceutical formulations highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving vaccine delivery methods.